Having the right information a click away can make all the difference and can fuel your innovation where it matters most — at the bench. Thomson Reuters provides reliable, detailed intelligence across multiple disciplines and from the perspective of a scientist to support successful drug R&D, from pathway analysis to clinical trials.
Thomson Reuters can help you:
- Uncover therapeutic and putative drug targets that relate to a disease with systems biology intelligence
- Analyze comprehensive biomarker intelligence in relation to drug discovery, patient stratification, translational medicine, or drug repositioning
- Understand the competitive landscape, e.g. targets, indications, drugs, competitors, clinical trials, and associated developments
- Assess structures of compounds and drugs in R&D and understand their structure-activity relationship and relate successful or failed trials data to a given structure